These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1707628

  • 1. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
    Patel KV, Schrey MP.
    J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Potent bombesin receptor antagonists distinguish receptor subtypes.
    von Schrenck T, Wang LH, Coy DH, Villanueva ML, Mantey S, Jensen RT.
    Am J Physiol; 1990 Sep; 259(3 Pt 1):G468-73. PubMed ID: 2169207
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH, Battey JF, Wada E, Lin JT, Mantey S, Coy DH, Jensen RT.
    Biochem J; 1992 Sep 01; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
    Woll PJ, Rozengurt E.
    Proc Natl Acad Sci U S A; 1988 Mar 01; 85(6):1859-63. PubMed ID: 2450349
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR, Weber HC, Hou W, Sainz E, Mantey SA, Battey JF, Coy DH, Jensen RT.
    J Biol Chem; 1998 May 29; 273(22):13613-24. PubMed ID: 9593699
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressin.
    Woll PJ, Rozengurt E.
    Growth Factors; 1988 May 29; 1(1):75-83. PubMed ID: 2483337
    [Abstract] [Full Text] [Related]

  • 13. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, Avis I, Cuttitta F, Mulshine JL, Moody TW.
    Cancer Res; 1991 Apr 01; 51(7):1798-802. PubMed ID: 1848479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB, Hildebrand P, Jeker LB, Pansky A, Eberle AN, Beglinger C.
    Regul Pept; 1994 Oct 21; 53(3):165-73. PubMed ID: 7531356
    [Abstract] [Full Text] [Related]

  • 16. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
    Mahmoud S, Palaszynski E, Fiskum G, Coy DH, Moody TW.
    Life Sci; 1989 Oct 21; 44(5):367-73. PubMed ID: 2536883
    [Abstract] [Full Text] [Related]

  • 17. Substance P-related antagonists inhibit vasopressin and bombesin but not 5'-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells.
    Seckl MJ, Newman RH, Freemont PS, Rozengurt E.
    J Cell Physiol; 1995 Apr 21; 163(1):87-95. PubMed ID: 7534771
    [Abstract] [Full Text] [Related]

  • 18. Antagonism by GRP(18-27) and substance P analogues on insulin release stimulated by GRP(18-27).
    Mukai H, Kawai K, Suzuki S, Yamashita K, Munekata E.
    Peptides; 1990 Apr 21; 11(1):173-5. PubMed ID: 1692992
    [Abstract] [Full Text] [Related]

  • 19. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion.
    Kull FC, Leban JJ, Landavazo A, Stewart KD, Stockstill B, McDermed JD.
    J Biol Chem; 1992 Oct 15; 267(29):21132-8. PubMed ID: 1400423
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells.
    Nyéki O, Rill A, Schon I, Orosz A, Schrett J, Bartha L, Nagy J.
    J Pept Sci; 1998 Dec 15; 4(8):486-95. PubMed ID: 9927255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.